Format

Send to

Choose Destination
See comment in PubMed Commons below
Antimicrob Agents Chemother. 2005 Apr;49(4):1404-9.

Susceptibility to antibiotics and beta-lactamase induction in murein hydrolase mutants of Escherichia coli.

Author information

  • 1Institute of Microbiology, Faculty of Biology, Warsaw University, Poland.

Abstract

The antibiotic susceptibilities and capabilities to induce beta-lactamases were studied in multiple Escherichia coli murein (peptidoglycan) hydrolase mutants. E. coli mutants lacking either three amidases, three amidases and one lytic transglycosylase, or six lytic transglycosylases showed higher levels of susceptibility to bacitracin, erythromycin, gallidermin, and vancomycin than the wild type. Mutant cells without three amidases lost viability in the presence of vancomycin and gallidermin, whereas the wild type was resistant to both antibiotics. Beta-lactamase induction was studied after introduction of a plasmid carrying the ampC and ampR genes. Upon addition of cefoxitin to the growth medium, the wild type as well as a mutant lacking all known amidases and DD-endopeptidases induced beta-lactamase, whereas a mutant lacking all known lytic transglycosylases was unable to induce beta-lactamase, showing that lytic transglycosylase activity is essential for beta-lactamase induction. Consequently, cells lacking lytic transglycosylase activity lysed in the presence of penicillin, despite the presence of the inducible beta-lactamase system. We discuss the potential of murein hydrolase inhibitors for antibiotic therapy.

[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk